Akira Hori
- Neurology top 5%
- Immunology and Allergy top 5%
- Oncology top 5%
- HER2/EGFR in Cancer Research 8
- Neurology top 10%
- Organic Chemistry top 5%
-
- Angiogenesis and VEGF in Cancer 9
- PI3K/AKT/mTOR signaling in cancer 4
-
- Spinal Dysraphism and Malformations 7
-
- Cancer Mechanisms and Therapy 7
-
- Pituitary Gland Disorders and Treatments 5
-
- Fetal and Pediatric Neurological Disorders 5
-
- Alzheimer's disease research and treatments 5
Akira Hori
98 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 124
- Neurology 312
- Immunology and Allergy 113
- Oncology 479
- Neurology 120
- Organic Chemistry 409
Countries citing papers authored by Akira Hori
This map shows the geographic impact of Akira Hori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Hori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Hori more than expected).
Fields of papers citing papers by Akira Hori
This network shows the impact of papers produced by Akira Hori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Hori. The network helps show where Akira Hori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akira Hori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2018 | 6 | |
| 3 | 2017 | 11 | |
| 4 | 2013 | 16 | |
| 5 | 2013 | 38 | |
| 6 | 2013 | 64 | |
| 7 | 2012 | 42 | |
| 8 | 2010 | 26 | |
| 9 | 2010 | 95 | |
| 10 | Abstract #1244: Monotherapeutic and combination antitumor activities of TAK-701, a humanized anti-hepatocyte growth factor neutralizing antibody, against multiple types of cancer | 2009 | 4 |
| 11 | 2007 | 17 | |
| 12 | CXCR4 Antagonists Identified as Anti-Cancer-Metastatic Agents | 2004 | 0 |
| 13 | 2003 | 80 | |
| 14 | 2003 | 236 | |
| 15 | 2002 | 27 | |
| 16 | 1997 | 13 | |
| 17 | 1994 | 11 | |
| 18 | 1991 | 2 | |
| 19 | 1988 | 27 | |
| 20 | 1988 | 8 |
About Akira Hori
Akira Hori is a scholar working on Process Chemistry and Technology, Neurology and Neurology, having authored 101 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), HER2/EGFR in Cancer Research (8 papers), Spinal Dysraphism and Malformations (7 papers), Cancer Mechanisms and Therapy (7 papers), Pituitary Gland Disorders and Treatments (5 papers), Fetal and Pediatric Neurological Disorders (5 papers), Alzheimer's disease research and treatments (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Neurology (312 citations), Immunology and Allergy (113 citations) and Oncology (479 citations). Akira Hori has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hiroshi Miki, Hidehisa Iwata, Shinichi Imamura, Yoshio Kozai, Yasufumi Sakura, Kenichiro Naito, Takeshi Fujita, Reiko Sasada, Etsuya Matsutani and Yuzuru Shimizu. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.